Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Enrollment completed in Entereg phase III program

April 19, 2006

Novel agents for hepatic disorders claimed in recent patents

April 18, 2006

Valeant to outlicense pradefovir

April 18, 2006

Serotonin necessary for liver regeneration

April 18, 2006

PAR-101 effective against C. difficile-associated diarrhea

April 18, 2006

Novel anti-HCV drugs reported by Merck and Istituto di Ricerche di Biologia Molecolare P. Angeletti

April 11, 2006

Novel inhibitors of hepatitis C virus replicon system identified

April 6, 2006

Remicade sBLA for pediatric Crohn's disease granted priority review

April 5, 2006

PowderMed's DNA vaccine for hepatitis B enters phase I trials

March 31, 2006

Novartis exercises option to inlicense valopicitabine

March 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...